Cardima completes $20M private sale of stock

Justine Varieur Cadet | | Health Imaging | Diagnostic Imaging
Cardima, a medical device company focused on the treatment of atrial fibrillation, reported that it has completed the private sale of approximately 18.52 million shares of common stock to an accredited investor for $20 million.

In addition, the Fremont, Calif.-based company will issue warrants to purchase approximately 5.56 million shares of common stock at an exercise price of $1.25 per share to the same investor.

Cardima's Chairman Tony Shum said the firm intends to use the funds to execute its commercial plans to support further product adoption and to repay outstanding loans.




Justine Varieur Cadet

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.